Advertisement
Advertisement
ACB
Aurora Cannabis Inc. Common Shares
3.48
USDSponsored
+0.17
+5.29%
Feb 06, 15:59 UTC -5
Closed
After-Market
3.50
+0.02
+0.43%
ACB Earnings Reports
Positive Surprise Ratio
ACB beat 11 of 36 last estimates.
31%
Next Report
Date of Next Report
Jun 16, 2026
Estimate for Q4 26 (Revenue/ EPS)
$100.17M
/$0.03
Implied change from Q3 26 (Revenue/ EPS)
+8.54%
/-75.00%
Implied change from Q4 25 (Revenue/ EPS)
+10.64%
/-106.82%
Aurora Cannabis Inc. Common Shares earnings per share and revenue
On Feb 04, 2026, ACB reported earnings of 0.12 USD per share (EPS) for Q3 26, missing the estimate of 0.21 USD, resulting in a -42.72% surprise. Revenue reached 92.29 million, compared to an expected 93.30 million, with a -1.08% difference. The market reacted with a -7.64% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 4 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 100.17 million USD, implying an decrease of -75.00% EPS, and increase of 8.54% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
FAQ
What were Aurora Cannabis Inc. Common Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Aurora Cannabis Inc. Common Shares reported EPS of $0.12, missing estimates by -42.72%, and revenue of $92.29M, -1.08% below expectations.
How did the market react to Aurora Cannabis Inc. Common Shares's Q3 2026 earnings?
The stock price moved down -7.64%, changed from $4.06 before the earnings release to $3.75 the day after.
When is Aurora Cannabis Inc. Common Shares expected to report next?
The next earning report is scheduled for Jun 16, 2026.
What are the forecasts for Aurora Cannabis Inc. Common Shares's next earnings report?
Based on 4
analysts, Aurora Cannabis Inc. Common Shares is expected to report EPS of $0.03 and revenue of $100.17M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement